Wiltrom Co., Ltd. (TPEX:6767)
25.10
+0.10 (0.40%)
Aug 26, 2026, 12:16 PM CST
Wiltrom Revenue
Wiltrom had revenue of 84.20M TWD in the quarter ending June 30, 2026, with 2.01% growth. This brings the company's revenue in the last twelve months to 314.09M, down -8.98% year-over-year. In the year 2025, Wiltrom had annual revenue of 311.77M, down -6.86%.
Revenue (ttm)
314.09M
Revenue Growth
-8.98%
P/S Ratio
3.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
979.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.77M | -22.96M | -6.86% |
| Dec 31, 2024 | 334.73M | 57.62M | 20.79% |
| Dec 31, 2023 | 277.11M | 70.25M | 33.96% |
| Dec 31, 2022 | 206.86M | 62.37M | 43.16% |
| Dec 31, 2021 | 144.50M | 42.13M | 41.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| Bioptik Technology Incorporation | 912.86M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 409.16M |
| Taiwan Biomaterial | 182.32M |
| S&S Healthcare Holding | 172.45M |
| PlexBio | 137.57M |